Annual Drug Patent Expirations for ZIMHI
Zimhi is a drug marketed by Adamis Pharms Corp and is included in one NDA.
The generic ingredient in ZIMHI is naloxone hydrochloride. Additional details are available on the naloxone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
